Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injecta…
USD101.59+0.34%vs prev. close
Performance
1W
+0.55%
1M
+1.23%
3M
+0.31%
1Y
+85.78%
YTD
+52.14%
Valuation
P/E
25.2
EPS TTM
4.03
Dividend yield
—
Size and risk
Market cap
$6.6B
Beta
0.03
Price history
LNTH price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Lantheus
LNTH
Drug Manufacturers - Specialty & Generic
Mkt cap (USD bn)
6.6
P/E
25.2
Div yld
—
1W
+0.6%
1M
+1.2%
3M
+0.3%
6M
+4.7%
1Y
+85.8%
YTD
+52.1%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Lantheus
LNTH
Drug Manufacturers - Specialty & Generic
6.6
25.2
—
+0.6%
+1.2%
+0.3%
+4.7%
+85.8%
+52.1%
Subscribe to Equity Analytics to compare LNTH with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.